Prawo i regulacje · 22/02/2019

DEA Requests Extension of Information Collection for Individual Manufacturing Quota for Controlled Substances and Ephedrine-like Compounds

The Drug Enforcement Administration (DEA) is seeking an extension of its information collection request for individual manufacturing quotas for controlled substances and ephedrine-like compounds, previously approved in 2018, without any changes.